-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Singular Genomics Systems (NASDAQ:OMIC) Stock Price Up 2%
Singular Genomics Systems (NASDAQ:OMIC) Stock Price Up 2%
Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Rating)'s share price rose 2% during trading on Tuesday . The company traded as high as $2.12 and last traded at $2.05. Approximately 73,542 shares were traded during trading, a decline of 47% from the average daily volume of 138,934 shares. The stock had previously closed at $2.01.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group decreased their target price on Singular Genomics Systems from $3.50 to $3.00 and set a "neutral" rating for the company in a report on Tuesday, November 8th.
Get Singular Genomics Systems alerts:Singular Genomics Systems Stock Performance
The firm has a 50-day moving average of $2.15 and a two-hundred day moving average of $2.89. The company has a quick ratio of 19.00, a current ratio of 20.18 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $146.36 million, a PE ratio of -1.64 and a beta of 0.84.
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) last announced its quarterly earnings results on Monday, November 7th. The company reported ($0.33) earnings per share for the quarter, beating the consensus estimate of ($0.37) by $0.04. Research analysts anticipate that Singular Genomics Systems, Inc. will post -1.37 EPS for the current year.Insider Activity at Singular Genomics Systems
In related news, insider Eli N. Glezer purchased 50,000 shares of Singular Genomics Systems stock in a transaction that occurred on Monday, December 12th. The stock was bought at an average cost of $2.00 per share, for a total transaction of $100,000.00. Following the completion of the transaction, the insider now owns 4,185,000 shares in the company, valued at $8,370,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 22.60% of the stock is owned by company insiders.
Institutional Trading of Singular Genomics Systems
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Bank of New York Mellon Corp increased its position in shares of Singular Genomics Systems by 12.5% in the third quarter. Bank of New York Mellon Corp now owns 149,558 shares of the company's stock valued at $374,000 after buying an additional 16,636 shares in the last quarter. EP Wealth Advisors LLC purchased a new stake in shares of Singular Genomics Systems in the third quarter valued at approximately $26,000. Balyasny Asset Management LLC purchased a new stake in shares of Singular Genomics Systems in the third quarter valued at approximately $26,000. State Street Corp increased its position in shares of Singular Genomics Systems by 9.1% in the third quarter. State Street Corp now owns 811,015 shares of the company's stock valued at $2,028,000 after buying an additional 67,455 shares in the last quarter. Finally, Platinum Investment Management Ltd. increased its position in shares of Singular Genomics Systems by 105.2% in the third quarter. Platinum Investment Management Ltd. now owns 881,068 shares of the company's stock valued at $2,203,000 after buying an additional 451,732 shares in the last quarter. 56.33% of the stock is currently owned by hedge funds and other institutional investors.
About Singular Genomics Systems
(Get Rating)
Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits.
Featured Stories
- Get a free copy of the StockNews.com research report on Singular Genomics Systems (OMIC)
- Is First Solar Stock is Flying Too Close to the Sun?
- What's the Outlook for META Stock in 2023?
- Can Investors Cash In On PayPal?
- These 3 Tech Stocks Are in for a Happier New Year
- Tyson Foods: Growth and Momentum at a Reasonable Price
Receive News & Ratings for Singular Genomics Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Singular Genomics Systems and related companies with MarketBeat.com's FREE daily email newsletter.
纳斯达克股价周二上涨2%,盘中一度涨至2.12美元,最新报2.05美元。当日成交量约为73,542股,较日均成交量138,934股下降47%。此前该股收盘价为2.01美元。
分析师设定新的价格目标
另外,高盛夫妇在11月8日星期二的一份报告中将他们对奇异基因组系统公司的目标价从3.50美元下调至3.00美元,并将该公司的评级定为“中性”。
到达奇异基因组学系统警报:奇异基因组学系统股票表现
该公司的50日移动均线切入位在2.15美元,200日移动均线切入位在2.89美元。该公司的速动比率为19.00,流动比率为20.18,债务权益比率为0.04。该公司市值为1.4636亿美元,市盈率为-1.64,贝塔系数为0.84。
奇异基因组系统公司(纳斯达克代码:OMIC-GET Rating)上一次公布季度收益是在11月7日(星期一)。该公司公布了本季度每股收益(0.33美元),比普遍预期的(0.37美元)高出0.04美元。研究分析师预计,单基因系统公司本年度的每股收益将达到1.37美元。单一基因组学系统公司的内部活动
在相关新闻中,内部人士伊莱·N·格雷泽在12月12日星期一的一笔交易中购买了50,000股奇异基因系统公司的股票。这只股票是以每股2.00美元的平均价格购买的,总交易额为100,000.00美元。交易完成后,这位内部人士现在拥有该公司418.5万股股份,价值837万美元。此次收购是在提交给美国证券交易委员会的一份文件中披露的,该文件可在美国证券交易委员会网站。22.60%的股份由公司内部人士持有。
单一基因组系统的制度性交易
一些机构投资者和对冲基金最近改变了他们在该业务中的头寸。纽约梅隆银行(Bank Of New York Mellon Corp)第三季度将其在Single Genome Systems的股票头寸增加了12.5%。纽约梅隆银行(Bank Of New York Mellon Corp)目前持有149,558股该公司股票,价值374,000美元,此前该公司在上一季度又购买了16,636股。EP Wealth Advisors LLC在第三季度购买了Single Genome Systems的新股份,价值约2.6万美元。Balyasny Asset Management LLC在第三季度购买了Single Genome Systems的新股份,价值约2.6万美元。道富集团在第三季度将其在Single Genome Systems的股票头寸增加了9.1%。道富银行目前持有811,015股该公司股票,价值2,028,000美元,上一季度又购买了67,455股。最后,铂金投资管理有限公司在第三季度将其在Single Genome Systems的持股比例提高了105.2%。铂金投资管理有限公司目前持有881,068股该公司股票,价值2,203,000美元,该公司在上个季度又购买了451,732股。56.33%的股票目前由对冲基金和其他机构投资者持有。
关于奇异基因组学系统
(获取评级)
单一基因组系统公司是一家生命科学技术公司,开发下一代测序和多组学技术,为研究人员和临床医生制造产品,促进科学和医学的发展。该公司制造G4仪器,一种台式下一代测序仪,用于产生基因测序结果,以及相关的消耗品套装菜单。
专题报道
- 免费获取StockNews.com关于奇异基因组系统(OMIC)的研究报告
- 第一太阳能股票是不是飞得离太阳太近了?
- 2023年元股票的前景如何?
- 投资者能从PayPal中获利吗?
- 这三只科技股将迎来一个更快乐的新年
- 泰森食品:合理价格的增长和动力
《奇异基因组学系统日报》获得新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收最新新闻的每日简明摘要和分析师对Single Genome Systems及相关公司的评级。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧